Dept of Radiology, National Jewish Health, Denver, CO, USA.
Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, USA.
Eur Respir J. 2018 Sep 17;52(3). doi: 10.1183/13993003.01384-2018. Print 2018 Sep.
We evaluated performance characteristics and estimated the minimal clinically important difference (MCID) of data-driven texture analysis (DTA), a high-resolution computed tomography (HRCT)-derived measurement of lung fibrosis, in subjects with idiopathic pulmonary fibrosis (IPF).The study population included 141 subjects with IPF from two interventional clinical trials who had both baseline and nominal 54- or 60-week follow-up HRCT. DTA scores were computed and compared with forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide, distance covered during a 6-min walk test and St George's Respiratory Questionnaire scores to assess the method's reliability, validity and responsiveness. Anchor- and distribution-based methods were used to estimate its MCID.DTA had acceptable reliability in subjects appearing stable according to anchor variables at follow-up. Correlations between the DTA score and other clinical measurements at baseline were moderate to weak and in the hypothesised directions. Acceptable responsiveness was demonstrated by moderate to weak correlations (in the directions hypothesised) between changes in the DTA score and changes in other parameters. Using FVC as an anchor, MCID was estimated to be 3.4%.Quantification of lung fibrosis extent on HRCT using DTA is reliable, valid and responsive, and an increase of ∼3.4% represents a clinically important change.
我们评估了数据驱动的纹理分析(DTA)的性能特征,并估计了其在特发性肺纤维化(IPF)患者中的最小临床重要差异(MCID)。该研究人群包括来自两项干预性临床试验的 141 名 IPF 患者,他们均具有基线和名义上的 54 或 60 周 HRCT 随访。计算了 DTA 评分,并与用力肺活量(FVC)、一氧化碳弥散量、6 分钟步行试验中所覆盖的距离和圣乔治呼吸问卷评分进行比较,以评估该方法的可靠性、有效性和反应性。使用锚定和分布方法来估计其 MCID。在根据随访时的锚定变量表现稳定的患者中,DTA 具有可接受的可靠性。DTA 评分与基线时其他临床测量值之间的相关性为中度至弱,且符合假设方向。DTA 评分变化与其他参数变化之间具有中度至弱的相关性(符合假设方向),表明具有可接受的反应性。使用 FVC 作为锚定,估计 MCID 为 3.4%。使用 DTA 对 HRCT 上的肺纤维化程度进行定量是可靠、有效的,且增加约 3.4%代表具有临床意义的变化。